Daiichi Sankyo Co., Ltd., Japan Vaccine Co., Ltd. and Sanofi K.K. announced that they will launch "Squarekids subcutaneous injection syringe", a 4-tetravalent combination vaccine (DPT-IPV) for the prevention of diphtheria, pertussis, tetanus and poliomyelitis (polio) on December 9, 2015.
Scientists have mapped out the genes that keep our cells alive, thereby revealing which genes are crucial in diseases like cancer.